Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/23/08 | Current report filing |
|
5 | ||
| 05/15/08 | Quarterly report pursuant to Section 13 or 15(d) |
|
26 | ||
| 05/12/08 | Certification by the NASDAQ Stock Exchange approving securities for listing |
|
1 | ||
| 05/09/08 | Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b) |
|
2 | ||
| 05/01/08 | Current report filing |
|
8 | ||
| 04/18/08 | Definitive proxy statements |
|
41 | ||
| 04/16/08 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 04/16/08 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 04/16/08 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 03/27/08 | Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405] |
|
63 |